Research & Clinical Development
Accelerate your journey seamlessly from Data to Drug Discovery
Navigating Complexity, Accelerating Drug Discovery
The journey of drug discovery and development is one of extraordinary complexity, characterized by low success rates, high costs, and intricate biological pathways. Researchers struggle with uncertainties at every stage, leading to wasted resources and delayed timelines. Adding to the challenge, modern advancements like cell and gene therapies and mRNA vaccines have created fragmented technologies that don’t address the drug discovery challenges appropriately.
Data silos and evolving regulatory requirements further complicate operations, with compliance consuming 15-25% of operating budgets and slowing progress.
At the forefront of tackling these challenges is mcube™, our flagship Data & AI platform, which is the foundation for drug discovery labs in some of the leading pharmaceutical enterprises. mcube™ empowers R&D teams to move confidently from discovery to preclinical stages, turning uncertainty into opportunity:
Scientific Data Lakehouse
Transforming Research Experience for Lab Scientists
Optimizing Lab Productivity with Performance
Clinical Development
Discover how we can enable research and clinical development to deliver breakthrough therapies faster.
mcube™ for Data & AI-enabled transformation in Life Sciences
With a rich history in the pharmaceutical industry, TCG Digital has consistently partnered with the world’s leading pharma companies to deliver better drugs. This is made possible by our deep domain expertise and our commitment to innovation. At the heart of our commitment lies our advanced data and AI platform, mcube™, with business logic at the core of it and expertise derived from partnerships with industry leaders like LabVantage (leading provider in LIMS), BioMax (a leader in semantics integration & search), and TCG LifeSciences (a key clinical research player)—all part of the TCG Group.
Our Clientele
US-based large pharma company
Transforming R&D and Drug Discovery with mcube™- based integrated AI solutions
PK Assay Analysis, leading to $1.3 million in annual cost savings
Genotyping Analysis, leading to $0.5 million in annual cost savings
- Gene Expression Analysis, leading to $0.5 million in annual cost savings
European biopharma
- Assay Analytics suite with up to 80% acceleration in analysis turnaround time, and reduced manual interventions
- Method Validation
- ICH M10 Automated compliant reporting to streamline reporting, ensuring higher compliance with regulatory standards
Industry Insights
How can you engage with us?
Consultation Workshop | Request a ROI Impact Report | Request Demonstration